Category
An Open Letter by Geoff Micks Head of Content & Research Executive Platforms Those of you who follow us on Twitter or LinkedIn may have already seen the ‘Save the Date’ announcement for Executive Platforms’ newest summit series, Pharma…
Continue reading
Reviewing how our industry’s business partnerships have changed over time. How will this trend continue into the future? Dividing the work and sharing the burden: How should biopharmaceutical companies align their objectives of cost management, risk management, productivity, and growth?…
Continue reading
Examining technologies, tools, and platforms to accelerate the pace of biopharmaceutical development How development velocity can affect clinical development and what we learn in this process Examining how acceleration impacts our quality, regulatory, and supply chain functions. How do we…
Continue reading
What is serialization? Global serialization mandates Impact on manufacturing and the pharma supply chain Implementation challenges Technologies – Now and into the future — George Skillin Sr. Director – Global Engineering Pfizer George Skillin is the Senior Director of Pfizer…
Continue reading
Discussing how the evolution of manufacturing processes and technologies have transformed the biopharmaceutical industry When does new manufacturing capabilities generating product innovations, and when does product development spur advances in manufacturing? Debating the role new tools, tactics, and technology will…
Continue reading
Debating the merits of nimble and flexible facilities versus manufacturing battleships Preparing your pilot plants and manufacturing facilities to move forward with Phase II-III approvals Forecasting requirements for optimizing manufacturing equipment, facilities and partners to increase speed to market Achieving…
Continue reading
Common drivers for success: Leveraging Artificial and Business Intelligence to deploy automated systems to detect abnormal performance Deploying an automated management alarm and escalation system; used emails and text messages to accelerate response to performance-impacting events Creating real-time management dashboards…
Continue reading
What do we mean when we talk about Quality Culture, and how has that changed over time? If we could start over from scratch, what would we want Quality Culture in our industry to look like? How do we move…
Continue reading
Building a roadmap towards a digital vision starts with the destination in mind Developing a cohesive strategy based on a modular step-wise approach provides solid groundwork for future growth Gaining efficiencies in scale up and scale out capabilities with a…
Continue reading
Learning about global talent trends influencing the job market for senior executives and those with critical, specialized skill sets Creating effective attraction, retention and development plans for top talent Navigating the generational talent gap in critical functions Understanding which leadership…
Continue reading
The Amazon-ization of Retail – How an industry-wide disruption unfolds The ongoing digitization of the Biopharma ecosystem – The transformation of drug delivery The Possible? Likely? Inevitable? Impacts on Tech Ops – Recent new roles analysis What it all means…
Continue reading
Addressing the state of the biopharmaceutical industry today: Which emerging trend will see the most growth? Embracing modular automation, PAT and continuous processing to increase agility, flexibility and improve efficiencies People and technology: How are these forces working together to…
Continue reading
Lean applications in Bio-Manufacturing is both complex and simple Sustaining lean performances in Bio-Manufacturing is both science and art Good versus Great Lean leadership… It matters Successful OE polynomial equation for Lean Bio-Manufacturing = … ? — Jacks Lee is…
Continue reading
Repetitive engagement survey results with no sustainable action plan for improvement? Meeting mania dominating each and every day? Data, metrics, KPI’s, and scorecards – Thermometers or Thermostats? OPEX tools and governance models that feel abstract and disconnected? Struggling with any…
Continue reading
Offering an overview of how breakthrough therapy designations have historically worked and how that process is changing Are we as an industry ready for major changes in how drug development is expedited? Discussing how our organizations’ Quality Culture must be…
Continue reading
